Sequence Similarity Clusters for the Entities in PDB 6IAP

Entity #1 | Chains: A
Natural cytotoxicity triggering receptor 1 protein, length: 182 (BLAST)
Sequence Similarity Cutoff Rank Chains in Cluster Cluster ID / Name Structural variation in cluster
100 % 2 2 41060
95 % 2 2 41420 Flexibility: Low
Max RMSD: 1.6, Avg RMSD: 1.6
PDBFlex
90 % 2 2 39462
70 % 2 2 35017
50 % 2 2 30366
40 % 22 32 1402
30 % 27 39 1187
Entity #2 | Chains: D
Fab NKp46-4 light chain protein, length: 211 (BLAST)
Sequence Similarity Cutoff Rank Chains in Cluster Cluster ID / Name
100 % 1 1 58318
95 % 1 1 47254
90 % 303 519 4
70 % 1483 2352 2
50 % 1854 2983 2
40 % 1854 2983 2
30 % 3766 6055 1
Entity #3 | Chains: E
Fab NKp46-4 heavy chain protein, length: 217 (BLAST)
Sequence Similarity Cutoff Rank Chains in Cluster Cluster ID / Name
100 % 1 1 83012
95 % 1 1 58186
90 % 1 1 54928
70 % 1792 2883 1
50 % 1887 3028 1
40 % 1887 3028 1
30 % 3767 6055 1
Entity #4 | Chains: H
Fab NKp46-1 heavy chain protein, length: 220 (BLAST)
Sequence Similarity Cutoff Rank Chains in Cluster Cluster ID / Name Structural variation in cluster
100 % 1 1 83014
95 % 2 2 34955 Flexibility: Low
Max RMSD: 1.1, Avg RMSD: 1.1
PDBFlex
90 % 2 2 39813
70 % 1793 2883 1
50 % 1888 3028 1
40 % 1888 3028 1
30 % 3768 6055 1
Entity #5 | Chains: L
Fab NKp46-1 light chain protein, length: 211 (BLAST)
Sequence Similarity Cutoff Rank Chains in Cluster Cluster ID / Name Structural variation in cluster
100 % 2 2 44607
95 % 133 227 74 Flexibility: Low
Max RMSD: 1.7, Avg RMSD: 0.9
PDBFlex
90 % 304 519 4
70 % 1484 2352 2
50 % 1855 2983 2
40 % 1855 2983 2
30 % 3769 6055 1

Instructions

In the table for each entity, view a list of similar sequences by selecting the link associated with the percentage cutoff.



View more detailed documentation on the redundancy reduction and sequence clustering procedure used by RCSB PDB.

You can also use the structure comparison tool to compare any 2 given structures


ACTION - (A) Select for download / view details OR (B) Select two chains for comparison
Rank PDB ID Entity ID Chains Description Details Taxonomy EC Number
1 4NZU 1 L 13PL heavy chain Fab 9606
2 4NZU 2 H 13PL light chain Fab 9606
3 1MJU 1 L IMMUNOGLOBULIN MS6-12 Fab fragment, LIGHT CHAIN 10090
4 1MJU 2 H IMMUNOGLOBULIN MS6-12 Fab fragment, HEAVY CHAIN 10090
5 4TRP 1 H Heavy chain of monoclonal antibody against neuroblastoma associated antigen 10090
6 4TRP 2 L Light chain of monoclonal antibody against neuroblastoma associated antigen 10090
7 1MEX 1 L Fab 29G12 light chain 10090
8 1MEX 2 H Fab 29G12 heavy chain 10090
9 3D9A 2 L Light Chain of HyHel10 Antibody Fragment (Fab) 10090
10 3D9A 3 H Heavy Chain of HyHel10 Antibody Fragment (Fab) 10090
11 4BUH 1 A, B CLONE M0418 SCFV 9606
12 3TV3 1 L PGT128 light chain, Ig lambda-2 chain C regions PGT128 light chain 9606
13 3TV3 2 H PGT128 heavy chain, Ig gamma-1 chain C region PGT128 heavy chain 9606
14 1NCW 1 L IMMUNOGLOBULIN IGG2A Antibody FAB fragment 4C6, light chain 10090
15 1NCW 2 H IMMUNOGLOBULIN IGG2A Antibody FAB fragment 4C6, heavy chain 10090
16 5YD4 1 A, C, E, G scFv 4B08 10090
17 5YD3 1 A, C, E, G scFv 4B08 10090
18 5UD9 1 H Fab heavy chain 9606
19 5UD9 2 L Light chain 9606
20 4P48 1 A Antibody scFv 180 9031
21 6DDM 1 A Anti-MICA Fab fragment light chain clone 1D5 10090
22 6DDM 3 B Anti-MICA Fab fragment heavy chain clone 1D5 10090
23 5TY6 1 H VRC 315 13-1b02 Fab Heavy chain 9606
24 5TY6 2 L VRC 315 13-1b02 Fab Light chain 9606
25 2XZC 1 H FAB A.17 HEAVY CHAIN 9606
26 2XZC 2 L FAB A.17 LIGHT CHAIN 9606
27 2XKN 1 A, C ANTI-EGFR ANTIBODY 7A7 FAB FRAGMENT LIGHT CHAIN (IGG1), RESIDUES 1-223 10090
28 2XKN 2 B, D ANTI-EGFR ANTIBODY 7A7 FAB FRAGMENT HEAVY CHAIN (IGG1), RESIDUES 1-216 10090
29 6MEE 1 A, C antibody HEPC74 Heavy Chain 9606
30 6MEE 2 B, D antibody HEPC74 Light Chain 9606
31 6BJZ 1 H 5c8 Fab Heavy chain 9606
32 6BJZ 2 L 5c8 Fab Light chain 9606
33 5KVG 2 L ZV-67 Antibody Fab Light Chain 10090
34 5KVG 3 H ZV-67 Antibody Fab Heavy Chain 10090
35 5WCA 1 H VRC315 27-1C08 Fab Heavy chain 9606
36 5WCA 2 L VRC315 27-1C08 Fab Light chain 9606
37 4XCF 1 L 4E10 Fab light chain 9606
38 4XCF 2 H 4E10 Fab heavy chain 9606
39 5KVF 2 L ZV-64 Antibody Fab Light Chain 10090
40 5KVF 3 H ZV-64 Antibody Fab Heavy Chain 10090
41 1RUP 1 L immunoglobulin igg2a, heavy chain fab 10090
42 1RUP 2 H immunoglobulin igg2a, light chain fab 10090
43 3ESU 1 F Antibody 14b7* light chain and antibody 14b7* heavy chain linked with a synthetic (GGGGS)4 linker 10090
44 1RUK 1 L immunoglobulin igg2a, light chain fab 10090
45 1RUK 2 H immunoglobulin igg2a, heavy chain fab 10090
46 5VXR 1 H MAb24 Variable Heavy Chain,MAb24 Variable Heavy Chain 10090
47 5VXR 2 L MAb24 Variable Light Chain,MAb24 Variable Light Chain 10090
48 5X08 1 H Fab 4E10 Heavy chain 9606
49 5X08 2 L Fab 4E10 Light chain 9606
50 6NB8 1 H S230 antigen-binding (Fab) fragment, heavy chain 9606
51 6NB8 2 L S230 antigen-binding (Fab) fragment, light chain 9606
52 6A76 1 L Light chain of the anti-human Robo1 antibody B5209B Fab 10090
53 6A76 2 H Heavy chain of the anti-human Robo1 antibody B5209B Fab 10090
54 6MEG 1 H antibody HEPC46 Heavy Chain 9606
55 6MEG 2 L antibody HEPC46 Light Chain 9606
56 4XAW 1 L 4E10 Fab light chain 9606
57 4XAW 2 H 4E10 Fab heavy chain 9606
58 4P49 1 A Antibody scFv B8 9031
59 3N9G 1 H Fab fragment of MAb CR4354, heavy chain 9606
60 3N9G 2 L Fab fragment of MAb CR4354, light chain 9606
61 4TUL 1 H Heavy chain of monoclonal antibody against neuroblastoma associated antigen 10090
62 4TUL 2 L Light chain of monoclonal antibody against neuroblastoma associated antigen 10090
63 5UCB 1 H Fab Heavy Chain 9606
64 5UCB 2 L Fab Light Chain 9606
65 2VXV 1 H HUMAN IGG ABT-325 9606
66 2VXV 2 L HUMAN IGG ABT-325 9606
67 6FRJ 1 H scFv-SM3 Although this structure is a ScFv, please follow the same numbering as shown in PDB entry 5OWP. 10090
68 4GXV 1 H, I Antibody 1F1, heavy chain 9606
69 4GXV 2 L, M Antibody 1F1, light chain 9606
70 2VXT 1 H MURINE IGG 125-2H 10090
71 2VXT 3 L MURINE IGG 125-2H 10090
72 6CR1 1 L Light chain of adalimumab EFab (VL-IgE CH2) 9606
73 6CR1 2 H Heavy chain of adalimumab EFab (VH-IgE CH2) 9606
74 1RUM 1 L immunoglobulin igg2a, light chain fab 10090
75 1RUM 2 H immunoglobulin igg2a, heavy chain fab 10090
76 2XZA 1 H FAB A.17 HEAVY CHAIN 9606
77 2XZA 2 L FAB A.17 LIGHT CHAIN 9606
78 2W60 1 A ANTI-CITRULLINATED COLLAGEN TYPE II FAB ACC4 10090
79 2W60 2 B ANTI-CITRULLINATED COLLAGEN TYPE II FAB ACC4 10090
80 5W24 1 L 5C4 Fab Light Chain 10090
81 5W24 2 H 5C4 Fab Heavy Chain 10090
82 4HPY 1 H CH59 Fab heavy chain 9606
83 4HPY 2 L CH59 Fab light chain 9606
84 3T65 1 B S25-2 FAB (IGG1K) heavy chain 10090
85 3T65 2 A S25-2 FAB (IGG1K) light chain 10090
86 5C6W 1 H, J Protein IGHV1-69-2,Ig lambda chain V-II region NIG-84 9606
87 4JG1 1 L Fab light chain 9606
88 4JG1 2 H Fab heavy chain 9606
89 6E65 1 L TB31F Fab light chain 9606
90 6E65 2 H TB31F Fab heavy chain 9606
91 3M8O 1 L IMMUNOGLOBULIN A1 LIGHT CHAIN Fab fragment 9606
92 3M8O 2 H IMMUNOGLOBULIN A1 HEAVY CHAIN Fab fragment 9606
93 5VF2 1 A scFv 2D10 10090
94 5I8C 1 A VRC34.01 Fab heavy chain 9606
95 5I8C 2 B VRC34.01 Fab light chain 9606
96 4O5L 1 L Fab F045-092 light chain 9606
97 4O5L 2 H Fab F045-092 heavy chain 9606
98 5MYX 1 A, C Fab c#24 light chain 10090
99 5MYX 2 B, D Fab c#24 heavy chain Pyroglutamate residue 1 (PCA) results from post-translational modification of original residue glutamine 1. 10090
100 3IFL 1 L 12A11 FAB antibody light chain 10090
101 3IFL 2 H 12A11 FAB antibody heavy chain 10090
102 5WK2 1 L M116 LIGHT CHAIN 9606
103 5WK2 2 H M116 HEAVY CHAIN FD 9606
104 3PP4 1 H GA101 Fab heavy chain 10090
105 3PP4 2 L GA101 Fab light chain 10090
106 3KDM 1 A, L Immunoglobulin light chain 9606
107 3KDM 2 B, H Immunoglobulin heavy chain 9606
108 5NIV 1 A Light chain of 5D3 Fab 10090
109 5NIV 2 B Heavy chain of 5D3 Fab 10090
110 5N4J 1 L LIGHT CHAIN 9606
111 5N4J 2 H HEAVY CHAIN the sequence provided include the cleavable tag 9606
112 2AJU 1 L ANTIBODY 7A1 FAB' IMMUNOGLOBULIN IGG1 KAPPA LIGHT CHAIN 10090
113 2AJU 2 H ANTIBODY 7A1 FAB' IMMUNOGLOBULIN IGG1 HEAVY CHAIN 10090
114 2AJV 1 L Antibody 7A1 Fab' IMMUNOGLOBULIN IGG1 KAPPA LIGHT CHAIN 10090
115 2AJV 2 H Antibody 7A1 Fab' IMMUNOGLOBULIN IGG1 HEAVY CHAIN 10090
116 5X4G 1 A 6H8 Fab heavy chain 10090
117 5X4G 2 B 6H8 Fab light chain 10090
118 3SY0 1 A S25-2 FAB (IGG1K) light chain 10090
119 3SY0 2 B S25-2 FAB (IGG1K) heavy chain 10090
120 4PTU 1 A Antibody pn132p2C05, light chain 9606
121 4PTU 2 B Antibody pn132p2C05, heavy chain 9606
122 4TPR 1 L If kappa light chain 10090
123 4TPR 2 H Fab heavy chain 10090
124 4HS6 2 A, L MRCT10.v362 Fab light chain 9606
125 4HS6 3 B, H MRCT10.v362 Fab heavy chain 9606
126 3IFN 1 H 12A11 FAB antibody heavy chain 10090
127 3IFN 2 L 12A11 FAB antibody light chain 10090
128 5U3P 1 H DH511.4 Fab Heavy Chain 9606
129 5U3P 2 L DH511.4 Fab Light Chain 9606
130 6BLA 1 H AMM01 Fab Heavy chain 9606
131 6BLA 2 L AMM01 Fab Light chain 9606
132 4TOY 1 H 35O22 Fab Heavy chain 9606
133 4TOY 2 L 35O22 Fab Light chain 9606
134 4TUO 1 A, C Heavy chain of monoclonal antibody against neuroblastoma associated antigen 10090
135 4TUO 2 B, D Light chain of monoclonal antibody against neuroblastoma associated antigen 10090
136 3NPS 2 B S4 FAB HEAVY CHAIN 9606
137 3NPS 3 C S4 FAB LIGHT CHAIN 9606
138 5I4F 1 A scFv 2D10 10090
139 1RUR 1 L immunoglobulin 13G5, light chain fab 10090
140 1RUR 2 H immunoglobulin 13G5, heavy chain fab 10090
141 5ADO 1 H FAB A.17 HEAVY CHAIN 9606
142 5ADO 2 L FAB A.17 LIGHT CHAIN 9606
143 5WN9 1 H scFv 2D10 9606
144 4XC3 1 L 4E10 Fab light chain 9606
145 4XC3 2 H 4E10 Fab heavy chain 9606
146 1X9Q 1 A 4m5.3 anti-fluorescein single chain antibody fragment antibody binding fragment 9606
147 4M5Y 1 H, I Fab 5J8 heavy chain 9606
148 4M5Y 2 L, M Fab 5J8 light chain 9606
149 4TQE 1 L If kappa light chain 10090
150 4TQE 2 H Fab heavy chain 10090
151 5YY4 1 A scFv 4B08 10090
152 4ISV 1 A 1C2 FAB LIGHT CHAIN 10090
153 4ISV 2 B 1C2 FAB HEAVY CHAIN 10090
154 4XC1 1 L 4E10 FAB LIGHT CHAIN 9606
155 4XC1 2 H 4E10 FAB HEAVY CHAIN 9606
156 5VSI 1 H CH1/Ckappa Fab heavy chain 9606
157 5VSI 2 L CH1/Ckappa Fab light chain 9606
158 5ODB 1 A D10 Fab fragment - heavy chain not modeled residues are not visible in the electron density map the Fab fragment was prepared from a antibody chimera containing the variable domains of the human D10 mAb and the constant domains of mouse IgG2a heavy chain and Ig-lambda light chain 9606
159 5ODB 2 B D10 Fab fragment - light chain not modeled residues are not visible in the electron density map the Fab fragment was prepared from a antibody chimera containing the variable domains of the human D10 mAb and the constant domains of mouse IgG2a heavy chain and Ig-lambda light chain 9606
160 4CMH 2 B HEAVY CHAIN OF SAR650984-FAB FRAGMENT 10090
161 4CMH 3 C LIGHT CHAIN OF SAR650984-FAB FRAGMENT 10090
162 5JXA 1 H VRC03 Heavy chain 9606
163 5JXA 2 L VRC03 Light chain 9606
164 3QHZ 1 H, I Human monoclonal antibody del2D1, Fab Heavy Chain Fab Heavy Chain 9606
165 3QHZ 2 L, M Human monoclonal antibody del2D1, Fab Light Chain Fab Light Chain 9606
166 3UJI 1 L Light chain of anti-HIV-1 V3 monoclonal antibody 2558 9606
167 3UJI 2 H Fab region of the heavy chain of anti-HIV-1 V3 monoclonal antibody 2558 9606
168 3NTC 1 L Fab light chain 10090
169 3NTC 2 H Fab heavy chain 10090
170 4YNY 1 A, C Heavy chain of antigen binding fragment, Fab 10116
171 4YNY 2 B, D Light chain of antigen binding fragment, Fab 10116
172 4TUK 1 H Heavy chain of monoclonal antibody against neuroblastoma associated antigen 10090
173 4TUK 2 L Light chain of monoclonal antibody against neuroblastoma associated antigen 10090
174 4YO0 1 A, C Heavy chain of antigen binding fragment, Fab 10116
175 4YO0 2 B, D Light chain of antigen binding fragment, Fab 10116
176 6AZM 1 A, C 580 germline antibody, light chain Fragment: Fab 9606
177 6AZM 2 B, D 580 germline antibody, heavy chain Fragment: Fab 9606
178 6BE3 1 H Fab (F598) Heavy Chain 9606
179 6BE3 2 L Fab (F598) Light Chain 9606
180 4NWU 1 H APE1551 Ab Fab heavy chain 9606
181 4NWU 2 L APE1551 Ab Fab light chain 9606
182 3HC4 1 H IMMUNOGLOBULIN IGG1 FAB, HEAVY CHAIN 9606
183 3HC4 2 L IMMUNOGLOBULIN IGG1 FAB, LIGHT CHAIN 9606
184 5VZR 1 A, H G4 antibody heavy chain Fab fragment 10090
185 5VZR 2 B, L G4 antibody light chain Fab fragment 10090
186 2W9D 1 H ICSM 18-ANTI-PRP THERAPEUTIC FAB HEAVY CHAIN 10090
187 2W9D 2 L ICSM 18-ANTI-PRP THERAPEUTIC FAB LIGHT CHAIN 10090
188 5EWI 1 H VRC38.01 Heavy Chain 9606
189 5EWI 2 L VRC38.01 Light Chain 9606
190 5E2W 1 L AT8 LIGHT CHAIN 10090
191 5E2W 2 H AT8 HEAVY CHAIN 10090
192 5MYK 1 A Fab c#17 light chain 10090
193 5MYK 2 B Fab c#17 heavy chain 10090
194 4NZR 1 H PGT135 heavy chain Fab 9606
195 4NZR 2 L PGT135 light chain Fab 9606
196 5MYO 1 A, C Fab c#6 light chain 10090
197 5MYO 2 B, D Fab c#6 heavy chain 10090
198 4HBC 1 H Antigen Binding Fragment, Immunoglobulin IgG - Heavy Chain 9986
199 4HBC 2 L Antigen Binding Fragment, Immunoglobulin IgG - Light Chain 9986
200 4AEH 1 H FAB ANTIBODY, HEAVY CHAIN VARIABLE DOMAIN, RESIDUES 1-231 10090
201 4AEH 2 L FAB ANTIBODY, LIGHT CHAIN VARIABLE DOMAIN, RESIDUES 1-214 10090
202 5UEL 1 H 354NC102 Fab Heavy Chain 9606
203 5UEL 2 L 354NC102 Fab Light Chain 9606
204 3UZQ 1 A anti-dengue Mab 4E11 Single chain variable fragment 10090
205 2V17 2 H MONOCLONAL ANTIBODY FAB FRAGMENT MN423 DISULPHIDE BRIDGE BETWEEN L214 AND H137 IS REDUCED 10090
206 2V17 3 L MONOCLONAL ANTIBODY FAB FRAGMENT MN423 DISULPHIDE BRIDGE BETWEEN L214 AND H137 IS REDUCED 10090
207 4J6R 2 H HEAVY CHAIN OF ANTIBODY VRC23 9606
208 4J6R 3 L LIGHT CHAIN OF ANTIBODY VRC23 9606
209 5E2V 1 L AT8 LIGHT CHAIN 10090
210 5E2V 2 H AT8 HEAVY CHAIN 10090
211 5SY8 1 H 10E8 FAB HEAVY CHAIN 9606
212 5SY8 2 L 10E8 FAB LIGHT CHAIN 9606
213 5OCK 1 L Human ACPA E4 Fab fragment - Light chain the N-terminal glutamine is posttranslationally modified to pyroglutamic acid 9606
214 5OCK 2 H Human ACPA E4 Fab fragment - Heavy chain the N-terminal glutamine is posttranslationally modified to pyroglutamic acid 9606
215 5DD1 1 H ANTI-HIV ANTIBODY DH570 FAB HEAVY CHAIN 9544
216 5DD1 2 L ANTI-HIV ANTIBODY DH570 FAB LIGHT CHAIN 9544
217 5JUE 1 L light chain of UIC2 Fab 10090
218 5JUE 2 H heavy chain of UIC2 Fab 10090
219 5CIN 1 H FAB 4E10 HEAVY CHAIN 9606
220 5CIN 2 L FAB 4E10 LIGHT CHAIN 9606
221 5A2J 1 H SCFV-SM3 CONTAINS BOTH H AND L CHAINS OF SCFV-SM3, CONNECTEDBY A LINKER. CHAIN L RESIDUES ARE NUMBERED FROM 1000. RESIDUES 6-115,20-129 10090
222 5JR1 1 H 10E8 heavy chain 9606
223 5JR1 2 L 10E8 mature light chain 9606
224 6CA7 1 L PCT64_13C light chain 9606
225 6CA7 2 H PCT64_13C heavy chain 9606
226 5VF6 1 A single chain variable fragment 9031
227 3CFB 1 A, L BLUE FLUORESCENT ANTIBODY EP2-19G2-KAPPA LIGHT CHAIN FAB 10090
228 3CFB 2 B, H BLUE FLUORESCENT ANTIBODY EP2-19G2-IGG2B HEAVY CHAIN FAB 10090
229 3WII 1 L, M anti-human ROBO1 antibody B2212A Fab light chain 10090
230 3WII 2 H, I anti-human ROBO1 antibody B2212A Fab heavy chain 10090
231 6K4Z 1 A, B scFv of C6 The fusion protein of expression tags (residues -2-0), the light chain (residues 1-108), linker GGGGSGGGGSGGGGS (residues 501-515), and the heavy chain (residues 1001-1113) 10090
232 5OB5 2 H fAb Heavy chain 9606
233 5OB5 3 L fAb Light chain 9606
234 3BKJ 1 L WO2 IgG2a Fab fragment Light Chain Kappa 10090
235 3BKJ 2 H WO2 IgG2a Fab fragment Heavy Chain 10090
236 5I66 1 A 8B6 antibody, heavy chain 10090
237 5I66 2 B 8B6 antibody, light chain 10090
238 4JAM 1 A, H ANTIGEN BINDING FRAGMENT OF HEAVY CHAIN of CH103 9606
239 4JAM 2 B, L ANTIGEN BINDING FRAGMENT OF LIGHT CHAIN of CH103 9606
240 6BZY 1 H 22D11 Heavy Chain 10090
241 6BZY 2 L 22D11 Light Chain 10090
242 3QQ9 1 C, L 101F LIGHT CHAIN 10090
243 3QQ9 2 D, H 101F HEAVY CHAIN 10090
244 5TKK 2 H mouse antibody vFP5.01 heavy chain 10090
245 5TKK 3 L mouse antibody vFP5.01 light chain 10090
246 5FGB 1 A, B Anti-HCV E2 Fab HC84-1 light chain 9606
247 5FGB 2 C, E Anti-HCV E2 Fab HC84-1 heavy chain 9606
248 5W6C 1 H UCA Fab heavy chain 9606
249 5W6C 2 L UCA Fab light chain 9606
250 5I1K 1 L FAB LIGHT CHAIN 9606
251 5I1K 2 H FAB HEAVY CHAIN 9606
252 3OZ9 1 L Fab NC-1 kappa light chain 10090
253 3OZ9 2 H Fab NC-1 IgG2a heavy chain 10090
254 4JDV 1 A, H Fab heavy chain NIH45-46 Germ-line HEAVY CHAIN, IG GAMMA-1 CHAIN 9606
255 4JDV 2 B, L Fab light chain NIH45-46 Germ-line Light CHAIN, IG Kappa 9606
256 5V7U 1 L CBTAU-22.1 Fab light chain 9606
257 5V7U 2 H CBTAU-22.1 Fab heavy chain 9606
258 5UEA 1 A, H Fab Heavy Chain 9606
259 5UEA 3 B, L Fab Light Chain 9606
260 4AL8 2 H FAB 2H12 HEAVY CHAIN 9606
261 4AL8 3 L FAB 2H12 LIGHT CHAIN 9606
262 3G5Y 1 A 175 light chain 10090
263 3G5Y 2 B 175 heavy chain 10090
264 5NMV 1 L Fab light chain 10088
265 5NMV 2 H Fab heavy chain 10088
266 4N8C 1 H, I Heavy chain of monoclonal antibody 10090
267 4N8C 2 L, M Light chain of monoclonal antibody 10090
268 5AZ2 1 H anti-human epiregulin antibody 9E5 Fab heavy chain 10090
269 5AZ2 2 L anti-human epiregulin antibody 9E5 Fab light chain 10090
270 4HGW 1 A Antibody Fab fragment, light chain 10090
271 4HGW 2 B Antibody Fab fragment, heavy chain 10090
272 1NLB 1 L antibody 19D9D6 light chain 10090
273 1NLB 2 H antibody 19D9D6 heavy chain 10090
274 1C5C 1 L CHIMERIC DECARBOXYLASE ANTIBODY 21D8 THE CONSTANT DOMAIN (RESIDUES 103-214) IS FROM HUMAN SOURCE, AND THE VARIABLE DOMAIN (RESIDUES 1-102) IS FROM MURINE SOURCE FAB 10090
275 1C5C 2 H CHIMERIC DECARBOXYLASE ANTIBODY 21D8 THE CONSTANT DOMAIN (RESIDUES 109-230) IS FROM HUMAN SOURCE, AND THE VARIABLE DOMAIN (RESIDUES 1-108) IS FROM MURINE SOURCE FAB 10090
276 3VFG 1 L 3F8 Light Chain 10090
277 3VFG 2 H 3F8 Heavy Chain 10090
278 5TDN 1 A, C anti-HER2 Fab Light Chain 9606
279 5TDN 2 B, D anti-HER2 Fab Heavy Chain 9606
280 3QRG 1 L Fab light chain 9606
281 3QRG 2 H Fab heavy chain Fd fragment 9606
282 5M6A 1 A, B, C, D Bence-Jones light chain 9606
283 4LLY 1 A, C mutated Pertuzumab Fab heavy chain 9606
284 4LLY 2 B, D light chain Clambda 9606
285 4EBQ 1 H anti-Vaccinia D8L antigen monoclonal IgG2a antibody LA5, heavy chain Fab 10090
286 4EBQ 2 L anti-Vaccinia D8L antigen monoclonal IgG2a antibody LA5, light chain 10090
287 5EZI 1 H Fab c12 heavy chain 9606
288 5EZI 2 L Fab c12 Light chain 9606
289 4K23 1 H anti-uPAR antibody, heavy chain 10090
290 4K23 2 L anti-uPAR antibody, light chain 10090
291 3NCJ 1 L Fab15 Mut8 light chain 9606
292 3NCJ 2 H Fab15 Mut8 heavy chain 9606
293 3UO1 1 H ANTI-MHC-I MONOCLONAL ANTIBODY, 64-3-7 H CHAIN 10090
294 3UO1 2 L ANTI-MHC-I MONOCLONAL ANTIBODY, 64-3-7 L CHAIN 10090
295 4M1G 1 L Murine IgG2a A27D7 Light chain Fab domain 10090
296 4M1G 2 H Murine IgG2a A27D7 Heavy chain Fab domain 10090
297 5W05 1 L M59 FAB LIGHT CHAIN 10090
298 5W05 2 H M59 FAB HEAVY CHAIN FD 10090
299 2IPU 1 K, L IgG2a Fab fragment Heavy Chain 10090
300 2IPU 2 G, H IgG2a Fab fragment Light Chain Kappa 10090
301 3HC3 1 H IMMUNOGLOBULIN IGG1 FAB, LIGHT CHAIN 9606
302 3HC3 2 L IMMUNOGLOBULIN IGG1 FAB, HEAVY CHAIN 9606
303 4M61 1 A, C Fab A52 light chain 10090
304 4M61 2 B, D Fab A52 heavy chain 10090
305 5YE3 1 B 2A7D9 VH CH1 chain 10090
306 5YE3 2 A 2A7D9 L chain 10090
307 3BKM 1 L WO2 IgG2a Fab fragment Light Chain Kappa 10090
308 3BKM 2 H WO2 IgG2a Fab fragment Heavy Chain 10090
309 1UM5 1 L Antibody 21H3 L chain 10090
310 1UM5 2 H Antibody 21H3 H chain 10090
311 3QHF 1 H Human monoclonal antibody del2D1, Fab Heavy Chain Fab Heavy Chain 9606
312 3QHF 2 L Human monoclonal antibody del2D1, Fab Light Chain Fab Light Chain 9606
313 4NWT 1 L APE1531 Ab Fab light chain 9606
314 4NWT 2 H APE1531 Ab Fab heavy chain 9606
315 3WHX 1 A mAb Fab H fragment 10090
316 3WHX 2 B mAb Fab L fragment 10090
317 3NA9 1 L Fab15 light chain 9606
318 3NA9 2 H Fab15 heavy chain 9606
319 3BAE 1 L WO2 IgG2a Fab fragment Light Chain Kappa 10090
320 3BAE 2 H WO2 IgG2a Fab fragment Heavy Chain 10090
321 6RCO 1 A, C R5.004 heavy chain 9606
322 6RCO 2 B, D R5.004 light chain 9606
323 1NGZ 1 A Germline Metal Chelatase Catalytic Antibody, Light chain germline Fab fragment 10090
324 1NGZ 2 B Germline Metal Chelatase Catalytic Antibody, Heavy chain germline Fab fragment 10090
325 4LRI 1 A, B MSL-109 Light Chain 9606
326 4LRI 2 C, P MSL-109 Heavy Chain 9606
327 4ZTP 1 L Light chain of Fab fragment of rabbit monoclonal antibody R53 9986
328 4ZTP 2 H Heavy chain of Fab fragment of rabbit monoclonal antibody R53 9986
329 4JN2 1 A, L anti dabigatran Fab 10090
330 4JN2 2 B, H anti dabigatran Fab 10090
331 4XBE 1 L 4E10 FAB LIGHT CHAIN 9606
332 4XBE 2 H 4E10 Fab heavy chain 9606
333 1MJ8 1 L IMMUNOGLOBULIN MS6-126 Fab Fragment, LIGHT CHAIN 10090
334 1MJ8 2 H IMMUNOGLOBULIN MS6-126 Fab Fragment, HEAVY CHAIN 10090
335 6BE2 1 H Fab (F598) Heavy Chain 9606
336 6BE2 2 L Fab (F598) Light Chain 9606
337 4JFZ 1 L Fab light chain 9606
338 4JFZ 2 H Fab heavy chain 9606
339 6ARP 1 A, C Cetuximab mutant light chain,Uncharacterized protein 9606
340 6ARP 2 B, D Cetuximab mutant Fab heavy chain,Immunoglobulin gamma-1 heavy chain 9606
341 3WIF 1 A mAb Fab H fragment 10090
342 3WIF 2 B mAb Fab L fragment 10090
343 5U6A 1 A Light Chain 9606
344 5U6A 2 B Heavy Chain 9606
345 5KVD 2 L ZV-2 Antibody Fab Light Chain 10090
346 5KVD 3 H ZV-2 Antibody Fab Heavy Chain 10090
347 3MBX 1 L X836 LIGHT CHAIN 10090
348 3MBX 2 H X836 HEAVY CHAIN CHIMERIC MOLECULE OF MOUSE VARIABLE DOMAIN AND HUMAN CONSTANT DOMAIN, FD fragment 10090
349 3TWC 1 L PGT127 light chain, Ig lambda-2 chain C regions 9606
350 3TWC 2 H PGT127 heavy chain, Ig gamma-1 chain C region 9606
351 6APC 1 H Epididymis luminal protein 214 9606
352 6APC 2 L IGL@ protein 9606
353 4HHA 1 A Fab KE5 Fab fragment KE5 9606
354 4HHA 2 B Antibody KE5 AD-2S1 eptiope 9606
355 6FZQ 1 H scFv-1SM3,scFv-1SM3 10090
356 5A2K 1 H IG LAMBDA-1 CHAIN V REGION S43 RESIDUES 6-115,20-129 10090
357 4RGO 2 H 14G8 heavy chain Fab 10090
358 4RGO 3 L 14G8 light chain Fab 10090
359 5N7B 1 H Ig heavy chain V-III region J606,Ig lambda-1 chain V region S43 Please follow the numbering described in the PDB entry 5A2K 10090
360 5GRY 1 A, G diabody 9606
361 5UEK 2 H Fab 12E Heavy Chain 9606
362 5UEK 3 L Fab 12E Light Chain 9606
363 3NAA 1 L Fab15 Mut5 light chain 9606
364 3NAA 2 H Fab15 Mut5 heavy chain 9606
365 1Q0X 1 L Fab 9B1, light chain 10090
366 1Q0X 2 H Fab 9B1, heavy chain 10090
367 4R90 1 L Anti CD70 Llama glama Fab 27B3 Light chain 9844
368 4R90 2 H Anti CD70 Llama glama Fab 27B3 Heavy chain 9844
369 4XVT 2 H donor 45 45-VRC01.H01+07.O-863513/45-VRC01.L01+07.O-110653 (VRC07_1995) Heavy chain 9606
370 4XVT 3 L 45-VRC01.H01+07.O-863513/45-VRC01.L01+07.O-110653 (VRC07_1995) Light chain 9606
371 5IK3 1 A, C 1E03 Fab fragment heavy chain 9606
372 5IK3 2 B, D 1E03 Fab fragment light chain 9606
373 5NPH 2 H Heavy chain of Fab fragment derived from non-neutralizing antibody DAO5 10090
374 5NPH 3 L Light chain of Fab fragment derived from non-neutralizing antibody DAO5 10090
375 5XLI 1 a, b FabL 10090
376 5XLI 2 c, d FabH 10090
377 5IHZ 1 A, C, E, H 1E01 Fab fragment heavy chain 9606
378 5IHZ 2 B, D, F, L 1E01 Fab fragment light chain 9606
379 6DC4 1 H Fab AM22 Heavy Chain 9606
380 6DC4 2 L Fab AM22 Light Chain 9606
381 2R1X 1 A Fab, antibody fragment (IgG1k), light chain 10090
382 2R1X 2 B Fab, antibody fragment (IgG1k), heavy chain 10090
383 5U3D 1 A MEMAB TRASTUZUMAB FAB LIGHT CHAIN I83E 9606
384 5U3D 2 B MEMAB TRASTUZUMAB FAB HEAVY CHAIN 9606
385 4WUK 1 H CH65 heavy chain 9606
386 4WUK 2 L CH65 light chain 9606
387 3MLY 1 L, M Human monoclonal anti-HIV-1 gp120 V3 antibody 3074 Fab light chain 9606
388 3MLY 2 H, I Human monoclonal anti-HIV-1 gp120 V3 antibody 3074 Fab heavy chain 9606
389 5U3O 1 H DH511.2_K3 Fab Heavy Chain 9606
390 5U3O 2 L DH511.2_K3 Fab Light Chain 9606
391 5JOP 1 D, L Fab 14.22 light chain 10090
392 5JOP 2 E, H Fab14.22 heavy chain 10090
393 4HPO 1 H CH58 Fab heavy chain 9606
394 4HPO 2 L CH58 Fab light chain 9606
395 5UKN 1 H DH522UCA Fab fragment heavy chain 9544
396 5UKN 2 L DH522UCA Fab fragment light chain 9544
397 6BHZ 1 H, I Trastuzumab Anti-HER2 Fab Heavy Chain 9606
398 6BHZ 2 L, M Trastuzumab Anti-HER2 Fab Light Chain D185A 9606
399 5IT2 1 H heavy chain 9606
400 5IT2 2 L light chain 9606
401 6MY4 1 A, H anti-VEGF-A Fab fragment bH1 heavy chain 9606
402 6MY4 2 B, L anti-VEGF-A Fab fragment bH1 light chain 9606
403 4POZ 1 C light chain of Fab fragment of 10B9 antibody 10090
404 4POZ 2 D heavy chain of Fab fragment of 10B9 antibody 10090
405 4F57 1 L Light chain of Fab of a neutralizing antibody L1 light chain of L1 9606
406 4F57 2 H Heavy chain of Fab of a neutralizing antibody L1 heavy chain of L1 9606
407 5MO3 2 H Fab of monoclonal antibody, heavy chain 10090
408 5MO3 3 L Fab of monoclonal antibody, light chain 10090
409 5GZ0 1 A, C FM329 light chain 1383439
410 5GZ0 2 B, D FM329 heavy chain 1383439
411 6DW2 1 A 6078 Fab light chain 9606
412 6DW2 2 B 6078 Fab heavy chain 9606
413 6MG4 1 A, B JTO light chain 9606
414 6BQB 1 L MGG4 Fab light chain 9606
415 6BQB 2 H MGG4 Fab heavy chain 9606
416 4PUB 1 H DX-2930 HEAVY CHAIN 9606
417 4PUB 2 L DX-2930 LIGHT CHAIN 9606
418 6B14 1 H Heavy chain of Fab BL3-6S97N 10090
419 6B14 2 L Light chain of Fab BL3-6S97N 10090
420 5DD6 1 A, H ANTI-HIV ANTIBODY DH570.mut58 FAB HEAVY CHAIN 9544
421 5DD6 2 B, L ANTI-HIV ANTIBODY DH570.mut58 FAB LIGHT CHAIN 9544
422 3WIH 2 L, M anti-human ROBO1 antibody B2212A Fab light chain 10090
423 3WIH 3 H, I anti-human ROBO1 antibody B2212A Fab heavy chain 10090
424 5GS3 1 A, H diabody protein 9606
425 3CFC 1 H BLUE FLUORESCENT ANTIBODY EP2-19G2-IGG2B HEAVY CHAIN FAB 10090
426 3CFC 2 L BLUE FLUORESCENT ANTIBODY EP2-19G2-KAPPA LIGHT CHAIN FAB 10090
427 3V4U 1 H ANTI-MHC-I MONOCLONAL ANTIBODY, 64-3-7 H CHAIN 10090
428 3V4U 2 L ANTI-MHC-I MONOCLONAL ANTIBODY, 64-3-7 L CHAIN 10090
429 5VKD 2 H Fab Heavy Chain 9606
430 5VKD 3 L Fab light chain 9606
431 2R1Y 1 A Fab, antibody fragment (IgG1k), light chain 10090
432 2R1Y 2 B Fab, antibody fragment (IgG1k), heavy chain 10090
433 5XHG 1 A, C polypeptide(L) 10090
434 5XHG 2 B, D polypeptide(H) 10090
435 4XMP 2 H HEAVY CHAIN OF ANTIBODY VRC08 9606
436 4XMP 3 L LIGHT CHAIN OF ANTIBODY VRC08 9606
437 3UYR 1 H antibody Fab heavy chain 10090
438 3UYR 2 L antibody Fab light chain 10090
439 3V0W 1 L WN1 222-5 Fab (IgG2a) light chain 10090
440 3V0W 2 H WN1 222-5 Fab (IgG2a) heavy chain 10090
441 5OCX 1 L Fab fragment anti-citrullinated protein antibody E4 - light chain N-terminal glutamine is posttranslationally modified to pyroglutamic acid produced as chimera of human E4 mAb variable domains and mouse IgG2a constant domains 9606
442 5OCX 2 H Fab fragment of anti-citrullinated protein antibody E4 - heavy chain unmodelled residues not visible in electron density produced as chimera of human mAb E4 variable domains and mouse IgG2a constant domains 9606
443 1YQV 1 L HyHEL-5 Antibody Light Chain IG*G1 FAB FRAGMENT (HY/HEL-5) 10090
444 1YQV 2 H HyHEL-5 Antibody Heavy Chain IG*G1 FAB FRAGMENT (HY/HEL-5) 10090
445 3OAZ 1 H, M Fab 2G12, heavy chain Fab 9606
446 3OAZ 2 K, L Fab 2G12, light chain 9606
447 2R2B 1 A Fab, antibody fragment (IgG1k), light chain 10090
448 2R2B 2 B Fab, antibody fragment (IgG1k), heavy chain 10090
449 1ZAN 1 L Fab AD11 Light Chain 10116
450 1ZAN 2 H Fab AD11 Heavy Chain 10116
451 6CJK 1 A, C Immunoglobulin Fab light chain 9986
452 6CJK 2 B, D Immunoglobulin Fab heavy chain 9986
453 4N0Y 1 H IGH526 Heavy Chain 9606
454 4N0Y 2 L IGH526 Light Chain 9606
455 3V52 1 H ANTI-MHC-I MONOCLONAL ANTIBODY, 64-3-7 H CHAIN 10090
456 3V52 2 L ANTI-MHC-I MONOCLONAL ANTIBODY, 64-3-7 L CHAIN 10090
457 6OTC 2 H sFab H3 heavy chain 32630
458 6OTC 3 L sFab H3 light chain 32630
459 5MTH 1 A, H antibody Fab heavy chain 10090
460 5MTH 2 B, L antibody Fab light chain 10090
461 3GGW 1 A, C FAB F22-4 LIGHT CHAIN 10090
462 3GGW 2 B, D FAB F22-4 HEAVY CHAIN 10090
463 1RZF 1 L Fab E51 light chain 9606
464 1RZF 2 H Fab E51 heavy chain 9606
465 5ZMJ 1 H Heavy chain of a Fab fraction of human IgG P01857 (UniProt) is referred. 9606
466 5ZMJ 2 L Light chain of a Fab fraction of human IgG P0DOY2(UniProt) is referred. 9606
467 6MY5 1 A, H anti-VEGF-A Fab fragment bH1 heavy chain 9606
468 6MY5 2 B, L anti-VEGF-A Fab fragment bH1 light chain 9606
469 4KTE 1 H GE148 Heavy Chain Fab Fab fragment 9544
470 4KTE 2 L GE148 Light Chain Fab 9544
471 5I8O 1 H HMM5 antibody heavy chain 9606
472 5I8O 2 L HMM5 antibody light chain 9606
473 4OUO 1 A anti Bla g 1 scFv 9031
474 4JG0 1 L Fab light chain 9606
475 4JG0 2 H Fab heavy chain 9606
476 4YGV 1 A, F aDabi-Fab2a heavy chain 9606
477 4YGV 2 B, L aDabi-Fab2a light chain 9606
478 5U4R 1 A, H VRC 315 53-1A09 Fab Heavy chain 9606
479 5U4R 2 B, L VRC 315 53-1A09 Fab Light chain 9606
480 5ALC 1 H ANTI-TICAGRELOR FAB 72, HEAVY CHAIN 9606
481 5ALC 2 L ANTI-TICAGRELOR FAB 72, LIGHT CHAIN 9606
482 5U5F 1 A MEMAB TRASTUZUMAB FAB LIGHT CHAIN I83E 9606
483 5U5F 2 B MEMAB TRASTUZUMAB FAB HEAVY CHAIN 9606
484 3EO0 1 A, C GC-1008 Fab Light Chain 10090
485 3EO0 2 B, D GC-1008 Fab Heavy Chain 10090
486 5CIL 1 H FAB 4E10 HEAVY CHAIN 9606
487 5CIL 2 L FAB 4E10 LIGHT CHAIN 9606
488 6BI2 1 H, I Trastuzumab Anti-HER2 Fab Heavy Chain 9606
489 6BI2 2 L, M Trastuzumab Anti-HER2 Fab Light Chain 9606
490 5F3B 1 A, E RK35 Chimeric antibody heavy chain 10090
491 5F3B 2 B, F RK35 Chimeric antibody light chain 10090
492 4FQI 3 H antibody CR9114 heavy chain Fab 9606
493 4FQI 4 L antibody CR9114 light chain Fab Lambda 9606
494 4JHA 1 H D25 antigen-binding fragment heavy chain 9606
495 4JHA 2 L D25 light chain 9606
496 6B9Z 1 A Trastuzumab Fab light chain 10090
497 6B9Z 2 B Trastuzumab Fab heavy chain CSO is partially oxidized cysteine 10090
498 3MCL 1 L C706 MONOCLONAL LIGHT CHAIN CHIMERIC MOLECULE OF MOUSE VARIABLE DOMAIN AND HUMAN CONSTANT DOMAIN 10090
499 3MCL 2 H C706 MONOCLONAL HEAVY CHAIN FD fragment of the heavy chain, CHIMERIC MOLECULE OF MOUSE VARIABLE DOMAIN AND HUMAN CONSTANT DOMAIN 10090
500 4PTT 1 A Antibody pn132p2C05, light chain 9606
501 4PTT 2 B Antibody pn132p2C05, heavy chain 9606
502 5OD0 1 L Fab fragment of ACPA E4 - Light chain the Fab fragment was prepared from a chimeric antibody containing the variable domain of human ACPA E4 and constant domains of mouse IgG2b the N-terminal Gln is posttranslationally modified to pyroglutamic acid 2 C-terminal residues not visible in electron density and therefore not modelled 9606
503 5OD0 2 H Fab fragment of ACPA E4 - heavy chain the Fab fragment was prepared from a chimeric antibody containing the variable domain of human ACPA E4 and constant domains of mouse IgG2b the N-terminal Gln is posttranslationally modified to pyroglutamic acid residues not modeled are not visible in the electron density map 9606
504 5KVL 1 H Humanized 10G4 anti-Leukotriene C4 Immunoglobulin G (IgG) heavy chain Fab fragment 9606
505 5KVL 2 L Humanized 10G4 anti-Leukotriene C4 Immunoglobulin G (IgG) light chain 9606
506 5TDO 1 A, C anti-HER2 Fab Light Chain 9606
507 5TDO 2 B, D anti-HER2 Fab Heavy Chain 9606
508 8FAB 1 A, C IGG1-LAMBDA HIL FAB (LIGHT CHAIN) 9606
509 8FAB 2 B, D IGG1-LAMBDA HIL FAB (HEAVY CHAIN) 9606
510 5NHW 1 H anti-human ActRII Bimagrumab Fab heavy-chain C-terminal FLAG-His6 tag Fab heavy-chain 9606
511 5NHW 2 L anti-human ActRII Bimagrumab Fab light-chain Fab light-chain 9606
512 2ZPK 1 L, M IgG1-lambda P20.1 Fab (light chain) 10090
513 2ZPK 2 H, I IgG1-lambda P20.1 Fab (heavy chain) Variable and Constant region 10090
514 4DGV 1 H HCV1 Heavy Chain Fab 9606
515 4DGV 2 L HCV1 Light Chain 9606
516 6C5K 1 A, H IgG1 Fab Heavy Chain 10090
517 6C5K 2 B, L IgG1 Fab Light Chain (Kappa) 10090
518 2DQU 1 L IMMUNOGLOBULIN 6D9 FAB FRAGMENT 10090
519 2DQU 2 H IMMUNOGLOBULIN 6D9 FAB FRAGMENT 10090
520 5TH2 1 A, C cetuximab Fab, light chain 10090
521 5TH2 2 B, D cetuximab Fab, heavy chain 10090
522 5I8K 1 L HHH1 Fab Light chain 9606
523 5I8K 2 H HHH1 Fab Heavy chain 9606
524 4YDL 2 B, H HEAVY CHAIN OF ANTIBODY C38-VRC18.02 9606
525 4YDL 3 C, L LIGHT CHAIN OF ANTIBODY C38-VRC18.02 9606
526 3T4Y 1 A S25-2 FAB (IGG1K) LIGHT CHAIN 10090
527 3T4Y 2 B S25-2 FAB (IGG1K) HEAVY CHAIN 10090
528 1YNL 1 L Ig gamma light chain 10090
529 1YNL 2 H Ig gamma heavy chain 10090
530 5EPM 1 A, E Antibody Fab fragment heavy chain 10090
531 5EPM 2 B, F Antibody Fab fragment light chain 10090
532 2AJS 1 L Antibody 7A1 FAB' IMMUNOGLOBULIN IGG1 kappa light chain 10090
533 2AJS 2 H Antibody 7A1 FAB' IMMUNOGLOBULIN IGG1 HEAVY CHAIN 10090
534 3UMT 1 A scFv heavy chain and light chain 10090
535 3BZ4 1 A, C, E, G Fab F22-4 light chain 10090
536 3BZ4 2 B, D, F, H Fab F22-4 heavy chain 10090
537 4NUJ 1 A PGT152 light chain 9606
538 4NUJ 2 B PGT152 heavy chain 9606
539 3LIZ 2 L 4C3 monoclonal antibody Light Chain 10090
540 3LIZ 3 H 4C3 monoclonal antibody Heavy Chain 10090
541 1RUA 1 L immunoglobulin igg2a, light chain fab 10090
542 1RUA 2 H immunoglobulin igg2a, heavy chain fab 10090
543 3U2S 1 A, H PG9 heavy chain antigen-binding fragment 9606
544 3U2S 2 B, L PG9 light chain 9606
545 6PE7 1 H FAB Heavy Chain 9606
546 6PE7 2 L FAB Light chain 9606
547 5D6C 1 A, L 4497 antibody IgK (VL and CL) 9606
548 5D6C 2 B, H 4497 antibody IgG1 (VH and CH1) 9606
549 4GAG 1 H NEUTRALIZING ANTIBODY AP33 HEAVY CHAIN 10090
550 4GAG 2 L NEUTRALIZING ANTIBODY AP33 LIGHT CHAIN 10090
551 2R23 1 A Fab, antibody fragment (IgG1k), light chain 10090
552 2R23 2 B Fab, antibody fragment (IgG1k), heavy chain 10090
553 4NUG 1 L PGT151 light chain 9606
554 4NUG 2 H PGT151 heavy chain 9606
555 3IU4 1 H chP3 Fab heavy chain 10090
556 3IU4 2 L chP3 Fab light chain 10090
557 3MNZ 2 A ANTI-HIV-1 ANTIBODY 13H11 LIGHT CHAIN mouse Fv,human Fc 10090
558 3MNZ 3 B ANTI-HIV-1 ANTIBODY 13H11 HEAVY CHAIN mouse Fv,human Fc 10090
559 6DC8 1 L IgG light chain 10090
560 6DC8 2 H IgG heavy chain 10090
561 3MLR 1 L Human monoclonal anti-HIV-1 gp120 V3 antibody 2557 Fab light chain 9606
562 3MLR 2 H Human monoclonal anti-HIV-1 gp120 V3 antibody 2557 Fab heavy chain 9606
563 1QYG 1 L FAB M82G2, LIGHT CHAIN 10090
564 1QYG 2 H FAB M82G2, HEAVY CHAIN 10090
565 6IAS 1 H Fab NKp46-1 heavy chain 32630
566 6IAS 2 L Fab NKp46-1 light chain 32630
567 1P7K 1 A, L antibody light chain FAB 10090
568 1P7K 2 B, H antibody heavy chain FAB 10090
569 6OBZ 1 A, H Heavy chain of FluA-20 Fab 9606
570 6OBZ 2 B, L Light chain of FluA-20 Fab, Immunoglobulin light chain 9606
571 3RVV 2 C 4C1 - light chain 10090
572 3RVV 3 D 4C1 - heavy chain 10090
573 5A2L 1 H SCFV-SM3 RESIDUES 6-115,20-129 10090
574 6GFE 2 L, M Immunoglobulin gamma-4 light chain 9606
575 3P0Y 2 H Fab DL11 heavy chain 9606
576 3P0Y 3 L Fab DL11 light chain 9606
577 4NPY 1 A, L germline PGT121 light chain Fab 9606
578 4NPY 2 B, H germline PGT121 heavy chain Fab 9606
579 6ANA 2 H LL2 Fab Heavy Chain 10090
580 6ANA 3 L LL2 Fab Light Chain 10090
581 5IBU 1 B, L 6652 Light Chain 9606
582 5IBU 2 G, H 6652 Heavy Chain 9606
583 5VPL 2 C 4C1 - LIGHT CHAIN 10090
584 5VPL 3 D 4C1 - HEAVY CHAIN 10090
585 6AOD 1 A FXIa Antibody FAB Light Chain 9606
586 6AOD 2 B FXIa Antibody FAB Heavy Chain 9606
587 5WCD 1 H VRC315 04-1D02 Fab Heavy chain 9606
588 5WCD 2 L VRC315 04-1D02 Fab Light chain 9606
589 2YPV 2 H FAB 12C1 10090
590 2YPV 3 L FAB 12C1 10090
591 4HH9 1 A, C Fab KE5, light chain KE5 Light chain 9606
592 4HH9 2 B, D Fab KE5, heavy chain KE5 Heavy Chain 9606
593 4JY5 1 L PGT122 light chain Fab 9606
594 4JY5 2 H PGT122 heavy chain Fab 9606
595 6ELE 1 A, H fAB heavy chain 9606
596 6ELE 2 B, L fAB light chain 9606
597 5UR8 1 A human immunoglobulin gamma, heavy chain Fd fragment 9606
598 5UR8 2 B human immunoglobulin gamma, kappa light chain 9606
599 6B5R 1 H CIS42 Fab Heavy chain 9606
600 6B5R 2 L CIS42 Fab Light chain 9606
601 3NAC 1 L Fab15 Mut7 light chain 9606
602 3NAC 2 H Fab15 Mut7 heavy chain 9606
603 5U5M 1 A MEMAB TRASTUZUMAB, LIGHT CHAIN 9606
604 5U5M 2 B MEMAB TRASTUZUMAB, HEAVY CHAIN 9606
605 2DQT 1 L IMMUNOGLOBULIN 6D9 FAB FRAGMENT 10090
606 2DQT 2 H IMMUNOGLOBULIN 6D9 FAB FRAGMENT 10090
607 1Q72 1 L Fab M82G2, Light chain 10090
608 1Q72 2 H Fab M82G2, Heavy chain 10090
609 4M1D 1 L, M Fab mAb 447-52D Light Chain 9606
610 4M1D 2 H, I Fab mAb 447-52D Heavy Chain 9606
611 6MNQ 2 H Ab DH727.2 heavy chain Fab fragment 9544
612 6MNQ 3 L Ab DH727.2 light chain 9544
613 1SEQ 1 L Monoclonal Antibody MNAC13 FAB Light Chain 10090
614 1SEQ 2 H Monoclonal Antibody MNAC13 FAB Heavy Chain 10090
615 4YHO 1 H aDabi-Fab3 heavy chain 9606
616 4YHO 2 L aDabi-Fab3 light chain 9606
617 6FZR 1 H scFv-SM3 Special processing instructions: Although this structure is a ScFv, please follow the same numbering as shown in PDB entry 5OWP. 10090
618 6NMT 1 A Fab 3 anti-SIRP-alpha antibody Variable Light Chain 9606
619 6NMT 2 B Fab 3 anti-SIRP-alpha antibody Variable Heavy Chain 9606
620 2R1W 1 A Fab, antibody fragment (IgG1k), light chain 10090
621 2R1W 2 B Fab, antibody fragment (IgG1k), heavy chain 10090
622 3MO1 1 A ANTI-HIV-1 ANTIBODY 13H11 LIGHT CHAIN FUSION PROTEIN between mouse Fv and a human Fc 10090
623 3MO1 2 B ANTI-HIV-1 ANTIBODY 13H11 HEAVY CHAIN FUSION PROTEIN between mouse Fv and a human Fc 10090
624 4DGY 1 H HCV1 Heavy Chain Fab 9606
625 4DGY 2 L HCV1 Light Chain 9606
626 5EN2 1 A GD01 heavy chain 10090
627 5EN2 2 B GD01 light chain 10090
628 3T77 1 A S25-2 FAB (IGG1K) light chain 10090
629 3T77 2 B S25-2 FAB (IGG1K) heavy chain 10090
630 6P4Y 1 H 4A10 Fab heavy chain 10090
631 6P4Y 2 L 4A10 Fab light chain 10090
632 3MXW 2 L 5E1 light chain 9606
633 3MXW 3 H 5E1 heavy chain 9606
634 2V7N 1 A, C, E, G IMMUNOGLOBULIN LIGHT CHAIN SYNTHETIC GENE, DERIVED FROM PHAGE DISPLAY OF THE HUMAN COMBINATORIAL ANTIBODY LIBRARY (HUCAL) FAB FRAGMENT, RESIDUES 1-255 32630
635 2V7N 2 B, D, F, H IMMUNOGLOBULIN HEAVY CHAIN SYNTHETIC GENE, DERIVED FROM PHAGE DISPLAY OF THE HUMAN COMBINATORIAL ANTIBODY LIBRARY (HUCAL) FAB FRAGMENT, RESIDUES 1-259 32630
636 3EO9 1 L Efalizumab Fab fragment, light chain 9606
637 3EO9 2 H Efalizumab Fab fragment, heavy chain 9606
638 4ALA 2 H FAB 2H12 HEAVY CHAIN 10090
639 4ALA 3 L FAB 2H12 LIGHT CHAIN 10090
640 6N35 1 K, L Fab 2G12 light chain 9606
641 6N35 2 H, M Fab 2G12 heavy chain 9606
642 4F33 1 A, C, E, G MORAb-009 FAB light chain 10090
643 4F33 2 B, D, F, H MORAb-009 FAB heavy chain 10090
644 3C6S 1 A, C, E, G Fab F22-4 light chain 10090
645 3C6S 2 B, D, F, H Fab F22-4 heavy chain 10090
646 5WUV 1 L light chain 9606
647 5WUV 2 H heavy chain 9606
648 4Z8F 1 H S1-15 Fab (IgG2b) heavy chain 10090
649 4Z8F 2 L S1-15 Fab (IgG2b kappa) light chain 10090
650 3OKL 1 A S25-39 Fab (IgG1k) light chain 10090
651 3OKL 2 B S25-39 Fab (IgG1k) heavy chain 10090
652 4JM4 1 H PGT 135 Heavy Chain Fab 9606
653 4JM4 2 L PGT 135 Light Chain Fab 9606
654 2HWZ 1 L Immunoglobulin Fab light chain Humanized mouse antibody MEDI-493 Anti-respiratory syncytial virus antibody 10090
655 2HWZ 2 H Immunoglobulin Fab heavy chain Humanized mouse antibody MEDI-493 Anti-respiratory syncytial virus antibody 10090
656 5YE4 1 A, C 1A9D7 VH CH1 chain 10090
657 5YE4 2 B, D 1A9D7 L chain 10090
658 6B0G 1 C 1245 Antibody, Light Chain 9606
659 6B0G 2 D 1245 Antibody, Heavy Chain 9606
660 5TDP 1 A, C anti-HER2 Fab Light Chain 9606
661 5TDP 2 B, D anti-HER2 Fab Heavy Chain 9606
662 1ZEA 1 L monoclonal anti-cholera toxin IGG1 KAPPA antibody, L chain 10090
663 1ZEA 2 H monoclonal anti-cholera toxin IGG1 KAPPA antibody, H chain 10090
664 6BAH 1 A Trastuzumab Fab light chain,Immunoglobulin kappa constant 10090
665 6BAH 2 B Trastuzumab Fab heavy chain,IGH@ protein 10090
666 6D0X 1 A 2140 Antibody, heavy chain 9606
667 6D0X 2 B 1210 Antibody, light chain 9606
668 6BE4 1 H Fab (F598) Heavy Chain 9606
669 6BE4 2 L Fab(F598) Light Chain 9606
670 5TPP 1 L DH270.5 Fab heavy chain 9606
671 5TPP 2 H DH270.5 Fab light chain 9606
672 5L88 1 H Anti-afamin antibody N14, Fab fragment, heavy chain 10090
673 5L88 2 L Anti-afamin antibody N14, Fab fragment, light chain 10090
674 1Q9W 1 A, C S45-18 Fab (IgG1k) light chain Fab1 Light chain kappa 10090
675 1Q9W 2 B, D S45-18 Fab (IgG1k) heavy chain Fab1 Heavy chain g1 10090
676 4P3C 1 H Heavy Chain Fab fragment of antibody LEM-2/15 MT1-MMP V-B loop 10090
677 4P3C 2 L Light Chain Fab fragment of antibody LEM-2/15 10090
678 1L7I 1 L chimera of Fab2C4: "humanized" murine monoclonal antibody The chimera consists of the human Ig and the original murine sequence light chain (residues 1-214) 9606
679 1L7I 2 H chimera of Fab2C4: "humanized" murine monoclonal antibody The chimera consists of the human Ig and the original murine sequence heavy chain (residues 1-216) 9606
680 1JPT 1 L immunoglobulin Fab D3h44, light chain Fab fragment 9606
681 1JPT 2 H immunoglobulin Fab D3H44, heavy chain Fab fragment 9606
682 1AQK 1 L FAB B7-15A2 IMMUNOGLOBULIN HUMAN FAB FAB 9606
683 1AQK 2 H FAB B7-15A2 IMMUNOGLOBULIN HUMAN FAB FAB 9606
684 5TL5 1 L M2177 LIGHT CHAIN 10090
685 5TL5 2 H M2177 HEAVY CHAIN 10090
686 2FX7 1 L Fab 4E10 Light Chain 9606
687 2FX7 2 H Fab 4E10 Heavy Chain 9606
688 6O39 1 A Antibody F2.I Fab, Light chain 9606
689 6O39 2 B Antibody F2.I Fab, Heavy chain 9606
690 5Y9K 1 L belimumab light chain 9606
691 5Y9K 2 H belimumab heavy chain 9606
692 4DTG 1 L Humanized recombinant FAB fragment, FAB 2021, of a murine antibody, light chain 9606
693 4DTG 2 H Humanized recombinant FAB fragment, FAB 2021, of a murine antibody, heavy chain 9606
694 5CSZ 1 A, H GANTENERUMAB FAB FRAGMENT HEAVY CHAIN FAB 9606
695 5CSZ 2 B, L GANTENERUMAB FAB FRAGMENT LIGHT CHAIN FAB 9606
696 6GLW 2 C, H Fab 1D11 - Heavy chain 9844
697 6GLW 3 D, L Fab 1D11 - Light chain 9844
698 3WFH 1 A mAb Fab H fragment 10090
699 3WFH 2 B mAb Fab L fragment 10090
700 4K3D 1 H, I BOVINE ANTIBODY WITH ULTRALONG CDR H3, HEAVY CHAIN 9913
701 4K3D 2 L, M BOVINE ANTIBODY WITH ULTRALONG CDR H3, LIGHT CHAIN 9913
702 4H8W 2 H FAB HEAVY CHAIN OF ADCC AND NON-NEUTRALIZING ANTI-HIV-1 ANTIBODY N5-I5 9606
703 4H8W 3 L FAB LIGHT CHAIN OF ADCC AND NON-NEUTRALIZING ANTI-HIV-1 ANTIBODY N5-I5 9606
704 3HNT 1 H CS-35 Fab Heavy Chain Heavy Chain 10090
705 3HNT 2 L CS-35 Fab Light Chain Light Chain 10090
706 6GKU 2 H Fab 6F5 - Heavy Chain 9844
707 6GKU 3 L Fab 6F5 - Light chain 9844
708 1WEJ 1 L E8 ANTIBODY IGG1 KAPPA MOUSE MONOCLONAL ANTIBODY FAB 10090
709 1WEJ 2 H E8 ANTIBODY IGG1 KAPPA MOUSE MONOCLONAL ANTIBODY FAB 10090
710 5VPG 2 C FAB 4C1 - LIGHT CHAIN 10090
711 5VPG 3 D FAB 4C1 - HEAVY CHAIN 10090
712 5HI4 2 C, H CAT-2000 FAB heavy chain 9606
713 5HI4 3 D, L CAT-2000 FAB light chain 9606
714 5NUZ 1 A, H eOD01 heavy chain Fab fragment (domains: variable heavy and constant heavy 1) Fab fragment (domains: variable heavy and constant heavy 1) 10090
715 5NUZ 2 B, L eOD01 light chain Fab fragment (domains: variable light and constant light) Fab fragment (domains: variable light and constant light) 10090
716 6QKD 1 H, I, J, K FAB HEAVY CHAIN 9844
717 6QKD 2 L, M, O, T FAB LIGHT CHAIN 9844
718 5FCU 2 H JR4 FAB HEAVY CHAIN 9544
719 5FCU 3 L JR4 FAB LIGHT CHAIN 9544
720 3RVW 2 C 4C1 - light chain 10090
721 3RVW 3 D 4C1 - heavy chain 10090
722 5DD3 1 H ANTI-HIV ANTIBODY DH570.4 FAB HEAVY CHAIN 9544
723 5DD3 2 L ANTI-HIV ANTIBODY DH570.4 FAB LIGHT CHAIN 9544
724 5XKU 2 B HNIgGA6 light chain 9606
725 5XKU 3 C HNIgGA6 heavy chain 9606
726 3D85 1 A FAB of antibody 7G10, light chain light chain 9606
727 3D85 2 B FAB of antibody 7G10, heavy chain heavy chain 9606
728 4Z95 1 H S1-15 Fab (IgG2b) heavy chain 10090
729 4Z95 2 L S1-15 Fab (IgG2b) light chain 10090
730 5HI5 2 C, H CAT-2000 FAB heavy chain 9606
731 5HI5 3 D, L CAT-2000 light chain 9606
732 5JO5 1 A, C, E, H 10E8 gHV 9606
733 5JO5 2 B, D, F, L 10E8 gLV 9606
734 5L9D 1 H MOUSE ANTIBODY FAB FRAGMENT, IGG1-KAPPA HEAVY CHAIN 10090
735 5L9D 2 L MOUSE ANTIBODY FAB FRAGMENT, IGG1-KAPPA LIGHT CHAIN 10090
736 5CCK 1 H Antibody 3BC315 Fab heavy chain 9606
737 5CCK 2 L Antibody 3BC315 Fab light chain 9606
738 6GXX 1 H FAB 1D9 heavy chain 10090
739 6GXX 2 L FAB 1D9 light chain 10090
740 5I76 1 A, C FM318_light_chain 1383439
741 5I76 2 B, D FM318_heavy_cahin 1383439
742 1KCV 1 L PC282 IMMUNOGLOBULIN light chain 10090
743 1KCV 2 H PC282 IMMUNOGLOBULIN heavy chain 10090
744 1FLR 1 L 4-4-20 (IG*G2A=KAPPA=) FAB FRAGMENT 10090
745 1FLR 2 H 4-4-20 (IG*G2A=KAPPA=) FAB FRAGMENT 10090
746 6MTT 1 L Antibody VRC46.01 Fb light chain 9606
747 6MTT 2 H Antibody VRC46.01 Fab heavy chain 9606
748 5I18 1 L FAB LIGHT CHAIN 9606
749 5I18 2 H FAB HEAVY CHAIN 9606
750 4JN1 1 H anti-dabigatran Fab1, heavy chain 10090
751 4JN1 2 L anti-dabigatran Fab1, light chain 10090
752 4P3D 1 A, H Heavy Chain Fab fragment of antibody LEM-2/15 10090
753 4P3D 2 B, L Light Chain Fab fragment of antibody LEM-2/15 10090
754 4G5Z 1 H canakinumab antibody fragment heavy chain 9606
755 4G5Z 2 L canakinumab antibody fragment light chain 9606
756 6HKG 1 A FISW84 Fab Fragment Heavy Chain 9606
757 6HKG 2 B FISW84 Fab Fragment Light Chain 9606
758 6HKG 3 C FISW84 Fab Fragment Heavy Chain 9606
759 3TNM 1 A, H Fab heavy chain of human anti-HIV-1 Env antibody A32 9606
760 3TNM 2 B, L Fab light chain of human anti-HIV-1 Env antibody A32 9606
761 2OK0 2 L Fab ED10 light chain 10090
762 2OK0 3 H Fab ED10 heavy chain 10090
763 3SOB 1 L antibody light chain 9606
764 3SOB 3 H antibody heavy chain 9606
765 6B5M 1 H CIS43 Fab Heavy chain 9606
766 6B5M 2 L CIS43 Fab Light chain 9606
767 5AWN 1 H Heavy chain of 3BC176 Fab 9606
768 5AWN 2 L Light chain of 3BC176 Fab 9606
769 4ZFO 2 L J22.9-xi Fab, Light Chain Fab Light Chain fragment of anti-BCMA antibody J22.9-xi 10090
770 4ZFO 3 A, H J22.9-xi Fab, Heavy Chain Fab Heavy Chain fragment of anti-BCMA antibody J22.9-xi 10090
771 4ZFO 4 B J22.9-xi Fab, Light Chain Fab Light Chain fragment of anti-BCMA antibody J22.9-xi 10090
772 4G6M 2 H heavy chain of gevokizumab antibody binding fragment 10090
773 4G6M 3 L light chain of gevokizumab antibody binding fragment 10090
774 5DR5 1 H AbD09097 Fab heavy chain The Fab heavy chain contains a C-terminal Myc- and hexahistidine extension preceded by thrombin peptidase recognition sequence to facilitate detection and purification 9606
775 5DR5 2 L AbD09097 Fab light chain 9606
776 6MG5 1 A, B Light chain JTO 9606
777 2IH3 1 A FAB Heavy Chain 10090
778 2IH3 2 B FAB Light Chain 10090
779 4KQ3 1 L CNTO3186 light chain Fab 9606
780 4KQ3 2 H CNTO3186 heavy chain Fab 9606
781 6AQ7 2 H POM6 FAB Heavy CHAIN 10090
782 6AQ7 3 L POM6 FAB light CHAIN 10090
783 4JFX 1 A, L Fab light chain 9606
784 4JFX 2 B, H Fab heavy chain 9606
785 3SGE 1 I, L Light Chain 10090
786 3SGE 2 H, J Heavy Chain 10090
787 1BM3 1 L IMMUNOGLOBULIN OPG2 FAB, CONSTANT DOMAIN CONSTANT DOMAIN 10090
788 1BM3 2 H IMMUNOGLOBULIN OPG2 FAB, VARIABLE DOMAIN VARIABLE DOMAIN 10090
789 4TUJ 1 A, C Heavy chain of monoclonal antibody against neuroblastoma associated antigen 10090
790 4TUJ 2 B, D Light chain of monoclonal antibody against neuroblastoma associated antigen 10090
791 2VXQ 2 H FAB H CHAIN OF THE FAB FRAGMENT COMPOSED OF THE IGE VARIABLE DOMAIN AND IGG CONSTANT DOMAIN 9606
792 2VXQ 3 L FAB L CHAIN OF THE FAB FRAGMENT COMPOSED OF THE IGE VARIABLE DOMAIN AND IGG CONSTANT DOMAIN 9606
793 2XWT 1 A THYROID BLOCKING HUMAN AUTOANTIBODY K1-70 HEAVY CHAIN FAB FRAGMENT HEAVY CHAIN, RESIDUES 1-229 9606
794 2XWT 2 B THYROID BLOCKING HUMAN AUTOANTIBODY K1-70 LIGHT CHAIN FAB FRAGMENT LIGHT CHAIN, RESIDUES 1-213 9606
795 5FHB 1 H Antibody 100 Fab heavy chain 9606
796 5FHB 2 L Antibody 100 Fab light chain 9606
797 3HZM 1 A S73-2 Fab (IgG1k) light chain 10090
798 3HZM 2 B S73-2 Fab (IgG1k) heavy chain 10090
799 1JGU 1 L Antibody Light Chain 10090
800 1JGU 2 H Antibody Heavy Chain 10090
801 4I77 1 H Lebrikizumab heavy chain Fab 9606
802 4I77 2 L Lebrikizumab light chain Fab 9606
803 4OCR 1 L CAP256-VRC26.01 light chain Fab 9606
804 4OCR 2 H CAP256-VRC26.01 heavy chain Fab 9606
805 4O4Y 1 L 2095-2 light chain SEE REMARK 999 9986
806 4O4Y 2 H 2095-2 heavy chain 9986
807 5OBF 1 H fAb Heavy chain 10090
808 5OBF 2 L fAb Light chain 10090
809 6QNK 1 A, C FAB light chain 10090
810 6QNK 2 B, D FAB heavy chain 10090
811 5LGH 1 H MOUSE ANTIBODY FAB FRAGMENT, IGG1-KAPPA HEAVY CHAIN IGG1-KAPPA HEAVY CHAIN, 1-214 10090
812 5LGH 2 L MOUSE ANTIBODY FAB FRAGMENT, IGG1-KAPPA LIGHT CHAIN IGG1-KAPPA LIGHT CHAIN, 1-214 10090
813 1UZ8 1 A, L IGG FAB (IGG3, KAPPA) LIGHT CHAIN 291-2G3-A FAB FRAGMENT LIGHT CHAIN, RESIDUES 1-212 10090
814 1UZ8 2 B, H IGG FAB (IGG3, KAPPA) HEAVY CHAIN 291-2G3-A FAB FRAGMENT HEAVY CHAIN, RESIDUES 1-213 10090
815 1DQQ 1 A, C ANTI-LYSOZYME ANTIBODY HYHEL-63 (LIGHT CHAIN) FAB FRAGMENT 10090
816 1DQQ 2 B, D ANTI-LYSOZYME ANTIBODY HYHEL-63 (HEAVY CHAIN) FAB FRAGMENT 10090
817 5L7X 1 H Mouse Antibody Fab Fragment, IgG1-kappa Heavy Chain IgG1-kappa heavy chain, 1-214 10090
818 5L7X 2 L Mouse Antibody Fab Fragment, IgG1-kappa Light Chain IgG1-kappa light chain, 1-214 10090
819 5V6M 1 L Light chain of Fab fragment of rabbit anti-HIV1 gp120 V3 mAb 10A3 9986
820 5V6M 2 H Heavy chain of Fab fragment of rabbit anti-HIV1 gp120 V3 mAb 10A3 9986
821 5MHE 1 L Fab-fragment 10090
822 5MHE 2 H Fab-fragment 10090
823 5YFI 1 L Light chain of Fab fragment 10090
824 5YFI 2 H Heavy chain of Fab fragment 10090
825 4GLR 2 H, J anti-ptau heavy chain heavy chain 9031
826 4GLR 3 I, K anti-ptau light chain light chain 9031
827 5WK3 1 P, R, T, V M116 LIGHT CHAIN 9606
828 5WK3 2 Q, S, U, W M116 HEAVY CHAIN FD 9606
829 6MTR 1 H Antibody VRC43.01 Fab heavy chain 9606
830 6MTR 2 L Antibody VRC43.01 Fab light chain 9606
831 4HJG 1 A Trastuzumab light chain 9606
832 4HJG 2 B Trastuzumab heavy chain 9606
833 5OWP 1 H Ig heavy chain V-III region J606,Ig lambda-1 chain V region H2020 10090
834 4M43 1 L Fragment antigen-binding 523-11 light chain 10090
835 4M43 2 H Fragment antigen-binding 523-11 heavy chain 10090
836 5I30 1 L Fab PL-2 light chain 10090
837 5I30 2 H Fab PL-2 heavy chain 10090
838 3HC0 1 A, H IMMUNOGLOBULIN IGG1 FAB, LIGHT CHAIN 9606
839 3HC0 2 B, L IMMUNOGLOBULIN IGG1 FAB, HEAVY CHAIN 9606
840 3BKC 1 L WO2 IgG2a Fab fragment Light Chain Kappa 10090
841 3BKC 2 H WO2 IgG2a Fab fragment Heavy Chain 10090
842 6CT7 1 B, L BIIB054 Fab light chain 9606
843 6CT7 2 A, H BIIB054 Fab heavy chain 9606
844 3FN0 1 L Fab Z13e1 light chain 9606
845 3FN0 2 H Fab Z13e1 heavy chain 9606
846 5X5X 1 H Fd chain of anti-osteocalcin antibody KTM219 10090
847 5X5X 2 L L chain of anti-osteocalcin antibody KTM219 10090
848 4YHI 1 A, H aDabi-Fab2a heavy chain 9606
849 4YHI 2 B, L aDabi-Fab2a light chain 9606
850 5NYX 1 H, M, O HEAVY CHAIN CHAIN H AND O ARE TWO SEPARATE POLYPEPTIDE CHAINS. fab heavy chains. The sequence provided contains the cleavable strep tag that has been removed prior to crystallisation 9606
851 5NYX 2 L, N, P LIGHT CHAIN fab light chain 9606
852 5YUP 1 H the heavy chain of the Fab fragment of FVIIa antibody mAb4F5 10090
853 5YUP 2 L the light chain of the Fab fragment of FVIIa antibody mAb4F5 10090
854 4OSU 1 H SM5-1 Fab Heavy Chain 9606
855 4OSU 2 L SM5-1 Fab Light Chain 9606
856 3MXV 1 L fab fragment of anti-Shh 5E1 mouse/human chimera, light chain 10090
857 3MXV 2 H fab fragment of anti-Shh 5E1 mouse/human chimera, heavy chain 10090
858 5IFA 1 H VRC01c-HuGL2 Fab heavy chain 9606
859 5IFA 2 L VRC01c-HuGL2 Fab light chain 9606
860 1T2Q 1 L Fab NNA7 Heavy Chain 10090
861 1T2Q 2 H Fab NNA7 Light Chain 10090
862 6ELJ 1 A, H fAB heavy chain 9606
863 6ELJ 2 B, L fAB light chain 9606
864 4G6K 1 H heavy chain of gevokizumab antibody binding fragment 10090
865 4G6K 2 L light chain of gevokizumab antibody binding fragment 10090
866 4MAU 1 L C2244 light chain SEE REMARK 999 10090
867 4MAU 2 H C2244 heavy chain FD, SEE REMARK 999 10090
868 3LEX 1 A, H 11f10 Antibody Heavy Chain 10090
869 3LEX 2 B, L 11f10 Antibody Light Chain 10090
870 6B0W 1 L 1710 antibody, light chain 9606
871 6B0W 2 H 1710 antibody, heavy chain 9606
872 6DC7 1 L, M Fab light chain 10090
873 6DC7 2 H, I Fab heavy chain 10090
874 5VH4 1 A, H Infliximab Fab Heavy Chain 10090
875 5VH4 2 B, L Infliximab Fab Light Chain 10090
876 6NOU 1 A scFv derived from ixekizumab 9606
877 5DQD 1 L S55-5 Fab (IgG1 kappa) light chain 10090
878 5DQD 2 H S55-5 Fab (IgG1) heavy chain 10090
879 5DT1 1 H Fab Heavy chain of broadly neutralizing antibody VRC26.25 9606
880 5DT1 2 L Fab Light chain of broadly neutralizing antibody VRC26.25 9606
881 4ONF 1 H 3D6 FAB ANTIBODY HEAVY CHAIN 10090
882 4ONF 2 L 3D6 FAB ANTIBODY LIGHT CHAIN 10090
883 1OPG 1 L OPG2 FAB (LIGHT CHAIN) 9606
884 1OPG 2 H OPG2 FAB (HEAVY CHAIN) 9606
885 1JPS 1 L immunoglobulin Fab D3H44, light chain Fab fragment 9606
886 1JPS 2 H immunoglobulin Fab D3H44, heavy chain Fab fragment 9606
887 5NPJ 1 A, B Single chain variable fragment of the non-neutralizing antibody DAO5 10090
888 1NBY 1 A antibody kappa light chain first chain of Anti-Lysozyme Antibody HyHEL-63 light chain 10090
889 1NBY 2 B immunoglobulin gamma 1 chain second chain of Anti-Lysozyme Antibody HyHEL-63 10090
890 3V6O 2 C, D Monoclonal antibody 9F8 fab fragment Heavy chain Fab fragment of monoclonal antibody H chain 10090
891 3V6O 3 E, F Monoclonal antibody 9F8 fab fragment Light chain Fab fragment of monoclonal antibody L chain 10090
892 3S96 1 A, C 3B5H10 FAB heavy chain 10090
893 3S96 2 B, D 3B5H10 FAB light chain 10090
894 6CBV 1 H Heavy chain, Fab fragment 9606
895 6CBV 2 L Light Chain, Fab fragment 9606
896 4LKX 1 A Fab fragment heavy chain 9606
897 4LKX 2 B Fab fragment light chain 9606
898 1Q9O 1 B, D S45-2 Fab (IgG1k) heavy chain Fab1 Heavy chain g1 10090
899 1Q9O 2 A, C S45-2 Fab (IgG1k) light chain Fab1 Light chain kappa 10090
900 3SE8 2 H Heavy chain of antibody VRC03 Antigen binding fragement of antibody heavy chain 9606
901 3SE8 3 L Light chain of antibody VRC03 antibody light chain 9606
902 5JW5 1 A, H MEDI8852 Heavy chain 9606
903 5JW5 2 B, L MEDI8852 Light chain 9606
904 5VH3 1 A, H Infliximab Fab Heavy Chain 10090
905 5VH3 2 B, L Infliximab Fab Light Chain 10090
906 6DCV 1 A, L Light chain of CBTAU27.1 Fab 9606
907 6DCV 2 B, H heavy chain of CBTAU-27.1 Fab 9606
908 5HDQ 2 H Fab Heavy Chain 10090
909 5HDQ 3 L Fab Light Chain 10090
910 4FQ2 1 H Fab heavy chain 9606
911 4FQ2 2 L Fab light chain 9606
912 3RKD 2 C, L Monoclonal Antibody, Light Chain 10090
913 3RKD 3 D, H Monoclonal Antibody, Heavy Chain 10090
914 3L1O 1 H MONOCLONAL ANTIBODY FAB FRAGMENT MN423 H CHAIN 10090
915 3L1O 2 L MONOCLONAL ANTIBODY FAB FRAGMENT MN423 L CHAIN 10090
916 2A77 1 L Immunoglobulin Light Chain 10090
917 2A77 2 H Immunoglobulin Heavy Chain